C141H139Br4F4N13O21 — CID 159288099
(2S)-2-[[2-[4-[[2-bromo-5-(4-hydroxypiperidine-1-carbonyl)phenyl]methoxy]-2-fluorophenyl]-1-cyclohexylbenzimidazole-5-carbonyl]amino]-3-(5-hydroxy-1H-indol-3-yl)propanoic acid;2-[4-[[2-bromo-5-(4-hydroxypiperidine-1-carbonyl)phenyl]methoxy]-2-fluorophenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;methyl 2-[4-[(5-acetyl-2-bromophenyl)methoxy]-2-fluorophenyl]-1-cyclohexylbenzimidazole-5-carboxylate;methyl 2-[4-[[2-bromo-5-(4-hydroxypiperidine-1-carbonyl)phenyl]methoxy]-2-fluorophenyl]-1-cyclohexylbenzimidazole-5-carboxylate (PubChem CID 159288099) has the molecular formula C141H139Br4F4N13O21 and a molecular weight of 2747.34 g/mol. Its IUPAC name is (2S)-2-[[2-[4-[[2-bromo-5-(4-hydroxypiperidine-1-carbonyl)phenyl]methoxy]-2-fluorophenyl]-1-cyclohexylbenzimidazole-5-carbonyl]amino]-3-(5-hydroxy-1H-indol-3-yl)propanoic acid;2-[4-[[2-bromo-5-(4-hydroxypiperidine-1-carbonyl)phenyl]methoxy]-2-fluorophenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;methyl 2-[4-[(5-acetyl-2-bromophenyl)methoxy]-2-fluorophenyl]-1-cyclohexylbenzimidazole-5-carboxylate;methyl 2-[4-[[2-bromo-5-(4-hydroxypiperidine-1-carbonyl)phenyl]methoxy]-2-fluorophenyl]-1-cyclohexylbenzimidazole-5-carboxylate.
| Compound Name | (2S)-2-[[2-[4-[[2-bromo-5-(4-hydroxypiperidine-1-carbonyl)phenyl]methoxy]-2-fluorophenyl]-1-cyclohexylbenzimidazole-5-carbonyl]amino]-3-(5-hydroxy-1H-indol-3-yl)propanoic acid;2-[4-[[2-bromo-5-(4-hydroxypiperidine-1-carbonyl)phenyl]methoxy]-2-fluorophenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;methyl 2-[4-[(5-acetyl-2-bromophenyl)methoxy]-2-fluorophenyl]-1-cyclohexylbenzimidazole-5-carboxylate;methyl 2-[4-[[2-bromo-5-(4-hydroxypiperidine-1-carbonyl)phenyl]methoxy]-2-fluorophenyl]-1-cyclohexylbenzimidazole-5-carboxylate |
|---|---|
| PubChem CID | 159288099 |
| Molecular Formula | C141H139Br4F4N13O21 |
| Molecular Weight | 2747.34 g/mol |
| Exact Mass | 2741.69 |
| IUPAC Name | (2S)-2-[[2-[4-[[2-bromo-5-(4-hydroxypiperidine-1-carbonyl)phenyl]methoxy]-2-fluorophenyl]-1-cyclohexylbenzimidazole-5-carbonyl]amino]-3-(5-hydroxy-1H-indol-3-yl)propanoic acid;2-[4-[[2-bromo-5-(4-hydroxypiperidine-1-carbonyl)phenyl]methoxy]-2-fluorophenyl]-1-cyclohexylbenzimidazole-5-carboxylic acid;methyl 2-[4-[(5-acetyl-2-bromophenyl)methoxy]-2-fluorophenyl]-1-cyclohexylbenzimidazole-5-carboxylate;methyl 2-[4-[[2-bromo-5-(4-hydroxypiperidine-1-carbonyl)phenyl]methoxy]-2-fluorophenyl]-1-cyclohexylbenzimidazole-5-carboxylate |
| SMILES | COC(=O)c1ccc2c(c1)nc(-c1ccc(OCc3cc(C(=O)N4CCC(O)CC4)ccc3Br)cc1F)n2C1CCCCC1.COC(=O)c1ccc2c(c1)nc(-c1ccc(OCc3cc(C(C)=O)ccc3Br)cc1F)n2C1CCCCC1.O=C(N[C@@H](Cc1c[nH]c2ccc(O)cc12)C(=O)O)c1ccc2c(c1)nc(-c1ccc(OCc3cc(C(=O)N4CCC(O)CC4)ccc3Br)cc1F)n2C1CCCCC1.O=C(O)c1ccc2c(c1)nc(-c1ccc(OCc3cc(C(=O)N4CCC(O)CC4)ccc3Br)cc1F)n2C1CCCCC1 |
| InChI | InChI=1S/C44H43BrFN5O7.C34H35BrFN3O5.C33H33BrFN3O5.C30H28BrFN2O4/c45-35-11-6-26(43(55)50-16-14-30(52)15-17-50)18-28(35)24-58-32-9-10-33(36(46)22-32)41-48-38-19-25(7-13-40(38)51(41)29-4-2-1-3-5-29)42(54)49-39(44(56)57)20-27-23-47-37-12-8-31(53)21-34(27)37;1-43-34(42)22-8-12-31-30(18-22)37-32(39(31)24-5-3-2-4-6-24)27-10-9-26(19-29(27)36)44-20-23-17-21(7-11-28(23)35)33(41)38-15-13-25(40)14-16-38;34-27-10-6-20(32(40)37-14-12-24(39)13-15-37)16-22(27)19-43-25-8-9-26(28(35)18-25)31-36-29-17-21(33(41)42)7-11-30(29)38(31)23-4-2-1-3-5-23;1-18(35)19-8-12-25(31)21(14-19)17-38-23-10-11-24(26(32)16-23)29-33-27-15-20(30(36)37-2)9-13-28(27)34(29)22-6-4-3-5-7-22/h6-13,18-19,21-23,29-30,39,47,52-53H,1-5,14-17,20,24H2,(H,49,54)(H,56,57);7-12,17-19,24-25,40H,2-6,13-16,20H2,1H3;6-11,16-18,23-24,39H,1-5,12-15,19H2,(H,41,42);8-16,22H,3-7,17H2,1-2H3/t39-;;;/m0.../s1 |
| InChIKey | KZTMZRNLFLOWJU-CQPJHTMKSA-N |
| XLogP | 29.63 |
| TPSA | 439.21 Ų |
| H-Bond Donors | 8 |
| H-Bond Acceptors | 27 |
| Rotatable Bonds | 32 |
| Heavy Atoms | 183 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2747.34 |
| LogP ≤ 5 | 29.63 |
| H-Bond Donors ≤ 5 | 8 |
| H-Bond Acceptors ≤ 10 | 27 |